New Chief Restructuring Officer and Chief Transformation Officer appointed
Schlieren/Switzerland, 24 November 2020
The news release can be downloaded from the following link:
Attachment
© 2020 GlobeNewswire, Inc. All Rights Reserved.
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis




